Molecular Millionaire: Jean-Paul Clozel of Actelion
Swiss biotech group Actelion CEO Jean-Paul Clozel arrives for his company's annual general meeting in Basel, May 5, 2011. REUTERS/Christian Hartmann (SWITZERLAND - Tags: BUSINESS HEALTH Stock Photo - Alamy
Wirtschafts-Deal des Jahres - Der Mann, der es tat – Jean-Paul Clozel verkaufte seine Actelion: «Manchmal packt mich Wehmut»
How is Actelion Spin-Off Idorsia Doing One Year Later?
Jean-Paul Clozel | EY - Global
Profile: Jean-Paul Clozel | Nature Biotechnology
PDF) Profile: Jean-Paul Clozel | charlie schmidt - Academia.edu
Ernst and Young's world Entrepreneur Dr Jean Paul Clozel | Flickr
38 Jean Paul Clozel Photos and Premium High Res Pictures - Getty Images
Actelion Began in a Garage—Now Its Founding Couple Has $1 Billion and a New Biotech Firm - WSJ
Actelion's Fate May Rest on Structure, Not Price, as Clozel Holds Firm - TheStreet
38 Jean Paul Clozel Photos and Premium High Res Pictures - Getty Images
Der Actelion-Gründer hat alle seine Ziele erreicht – und beginnt von vorn | NZZ
J&J seals $30bn Actelion deal in push for rare disease drugs - Gulf Times
Startup Guide - Jean-Paul and Martine Clozel are... | Facebook
Actelion CEO and founder Jean-Paul Clozel attends a news conference at Actelion headquarters in Allschwil, Switzerland January 26, 2017. REUTERS/Arnd Wiegmann Photo Stock - Alamy
Vor der Übernahme ein Rekordergebnis | Tages-Anzeiger
Actelion CEO Becomes a Billionaire With J&J's Bid for Drugmaker - Bloomberg
Jean-Paul Clozel
Jean-Paul Clozel - CEO @ Idorsia - Crunchbase Person Profile
Actelion Could Boost Takeover Price for Johnson & Johnson
Actelion's Jean-Paul Clozel aims to keep group's independence | Financial Times
Was plant das Ehepaar Clozel? | NZZ
